Key Highlights
- Shares of Cerebras declined 3.6% to close at $177.50 on Tuesday following the announcement of a Finnish AI data center partnership
- The Mikkeli-based facility will ultimately deliver 165 MW of IT capacity, with initial 50 MW construction already in progress
- Cathie Wood’s Ark Invest acquired approximately $17 million worth of CBRS shares on August 25, betting on AI inference expansion
- Second quarter revenue reached $180.1 million, representing 74% growth compared to the prior year, while cloud revenue exploded 287% YOY
- Analyst consensus stands at “Strong Buy” with a mean price target of $283.91, suggesting potential upside of approximately 59%
Shares of Cerebras Systems (CBRS) retreated 3.6% to $177.50 during Tuesday’s session, despite the AI chip manufacturer revealing a significant data center collaboration in Finland. The stock has declined over 42% during the past year and currently trades more than 15% beneath its 20-day moving average.
The Finnish agreement involves Compute Nordic Finland and centers on establishing an AI data center in the Mikkeli region. The infrastructure will be developed across multiple phases, ultimately delivering 165 MW of contracted IT capacity. The opening 50 MW phase has entered active construction.
Service contracts under this arrangement span seven-year periods, providing Cerebras with stable, long-term infrastructure to power its AI computing platform. The development is anticipated to generate employment opportunities within the Mikkeli area.
The stock’s decline despite favorable news isn’t particularly unusual. Broader market conditions were challenging, with the Nasdaq (QQQ) falling 1.5% and the S&P 500 declining 0.76%. AI infrastructure stocks typically correlate closely with overall growth market sentiment.
From a technical perspective, CBRS trades beneath both its 20-day SMA at $212.57 and its 50-day SMA at $203.90. The MACD indicator sits below its signal line with negative histogram values, suggesting diminishing bullish momentum. Critical support lies at $173.50, positioned just above the 52-week low of $160.81.
Ark Invest Increases Position
As shares retreated, Ark Invest increased its holdings. On August 25, Ark acquired 93,290 CBRS shares distributed across several ETFs, totaling approximately $17.2 million. This purchase follows additional accumulation earlier during August.
Wood’s investment rationale focuses on Cerebras’ leadership position in AI inference technology. The company’s CS-4 system delivers up to 30 times faster inference performance compared to GPU-based solutions. Cerebras is also collaborating with AMD on disaggregated inference architecture that provides up to five times greater throughput per watt in specific configurations.
The firm maintains strategic partnerships with OpenAI, AWS, and AMD, while simultaneously developing an inference cloud business alongside its hardware product line.
Impressive Growth, Premium Pricing
Cerebras delivered Q2 revenue of $180.1 million, representing 74% year-over-year expansion. Core revenue achieved $209.9 million, reflecting 103% YOY growth. Cloud and services revenue skyrocketed 287% YOY to $127.7 million, while core gross margin expanded to 41%.
Leadership increased full-year fiscal 2026 core revenue projections to a range of $880 million to $890 million. Third quarter core revenue guidance was set at $214 million to $216 million.
The company concluded Q2 holding $8.6 billion in cash, restricted cash, and short-term investments, alongside $25.4 billion in remaining performance obligations. Additionally, it maintains over 600 MW of data center capacity either operational or contracted.
The valuation carries a significant premium. With a market capitalization near $42.5 billion against annual sales of approximately $510 million, the price-to-sales multiple stands at 60 times. The company continues to report GAAP net losses.
Wall Street maintains optimism despite the elevated valuation. Among 11 analysts covering the stock, eight assign “Strong Buy” ratings, one rates it “Moderate Buy,” and two recommend “Hold.”
The consensus price target stands at $283.91. UBS maintains a $330 price objective, Morgan Stanley elevated its target to $279, and Wedbush increased its target to $290.
The upcoming earnings release is projected for November 19, 2026, with analyst expectations calling for revenue of $214.90 million and an EPS loss of 14 cents.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
